Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Current Pharmaceutical Design|April 14, 2017
Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and PerspectivesDimitry A Chistiakov, Veronika A Myasoedova, Alexander N Orekhov, et al.Current Pharmaceutical Design|November 19, 2016
Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on AtherosclerosisEkaterina A Ivanova, Veronika A Myasoedova, Alexandra A Melnichenko, et al.European Journal of Pharmacology|November 16, 2018
Sialidase activity in human pathologiesVictor Yu Glanz, Veronika A Myasoedova, Andrey V Grechko, et al.Drug Design, Development and Therapy|October 24, 2018
Inhibition of sialidase activity as a therapeutic approachVictor Yu Glanz, Veronika A Myasoedova, Andrey V Grechko, et al.Current Pharmaceutical Design|October 25, 2016
Epigenetically Active Drugs Inhibiting DNA Methylation and Histone DeacetylationDimitry A Chistiakov, Veronika A Myasoedova, Alexander N Orekhov, et al.Journal of Molecular and Cellular Cardiology|September 3, 2018
Matrix metalloproteinases in pro-atherosclerotic arterial remodelingVeronika A Myasoedova, Dimitry A Chistiakov, Andrey V Grechko, et al.Current Drug Metabolism|March 8, 2018
Phytotherapy for the Prevention of Atherosclerosis-Associated Early Cerebral IschemiaTatiana V Kirichenko, Veronika A Myasoedova, Igor A Sobenin, et al.Current Drug Targets|March 9, 2019
Trans-sialidase Associated with Atherosclerosis: Defining the Identity of a Key Enzyme Involved in the PathologyVictor Y Glanz, Veronika A Myasoedova, Andrey V Grechko, et al.International Journal of Molecular Sciences|August 13, 2020
Sex-Specific Features of Calcific Aortic Valve DiseaseVolha I Summerhill, Donato Moschetta, Alexander N Orekhov, et al.Experimental and Molecular Pathology|January 22, 2017
The phenomenon of atherosclerosis reversal and regression: Lessons from animal modelsDimitry A Chistiakov, Veronika A Myasoedova, Victor V Revin, et al.Pageof 8